Lexaria Bioscience Corp. Signs Second Tech Out-Licensing Agreement.
ByAinvest
Saturday, Jan 3, 2026 5:47 pm ET1min read
LEXX--
Lexaria Bioscience Corp. has entered a letter of intent to license its proprietary technology to CBDM LLC for the development and sale of marijuana oil infused products in Indian reservations and certain U.S. territories. Usage fees of $200,000 per product line are contemplated over a five-year operating term per state. The Licensee can earn non-exclusive rights to sell up to five product lines.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet